Search fresh public links, source activity, and post angles for Pharmacy Economics.
Fresh curated links around Pharmacy Economics are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
One of the central tensions in pharmaceutical policy is the gap between what a drug is worth and what it actually costs. In theory, a drug’s price should reflect its value — its ab...
By Bryce Platt, PharmD The onslaught of pharmacy-related news doesn’t end. It may even be increasing in volume due to AI. But don’t worry—I’ve gathered some high-impact inf...
Many comments and social media posts have highlighted the high prices of medicines in the country compared to neighbouring states, as this represents a significant financial burden...
Prescribing has evolved into a financial decision as much as a clinical one. As a result, one of the most consequential access moments is now occurring inside the electronic health...
Spring has officially arrived at Drug Channels' worldwide headquarters in beautiful downtown Philadelphia. (Photo proof at right.) So, dive into this month’s curated crop of notewo...
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....By: Latham &...
Most health care economics models are constructed from the perspective of a managed health care system such as those offered in Canada and several European countries, or from the p...
At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare dr...
As online pharmacies have grown in prominence, the German government aim to pass legislation to increase the profits of brick-and-mortar pharmacies in order to keep more physical l...
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....By: Latham &...
Stability continues to present pharmacy as a compelling, high-resilience investment opportunity, write Mike Hess and Dawn Perez-Slavinski of Bass, Berry & Sims. The post Why ph...
At the first-floor entrance of the new wing of Yongsan Etland, one of Korea’s largest electronics marketplaces, stands Medikingdom Pharmacy, a warehouse-style pharmacy that opened...
The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Once again, the specialty pharmacy market delivered a classic paradox: a sprawling, fragmented lan...
Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc. Peter explains that growing pressure on drug pricing is exposing structural inefficiencies i...
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....By: Latham &...
You walk into one pharmacy and pay $25 for a prescription, but what you may not realize is that the same medication costs $75 just...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.